Vyxeos
RxNorm concept 1942744, brand name (bn).
- RxCUI
- 1942744
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942744 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- daunorubicin liposomal (PIN, has precise ingredient)
- cytarabine liposome (PIN, has precise ingredient)
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] (SBDC, ingredient of)
- Vyxeos Injectable Product (SBDG, ingredient of)
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] (SBD, ingredient of)
- cytarabine / daunorubicin Injection [Vyxeos] (SBDF, ingredient of)
- cytarabine (IN, tradename of)
- daunorubicin (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1942744 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942744 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1942744. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.